Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 590
  • Home
  • Print this page
  • Email this page

 Table of Contents  
ORIGINAL ARTICLE
Year : 2018  |  Volume : 5  |  Issue : 3  |  Page : 337-341

A Study on Cervical Cancer Screening Using Pap Smear Test and Clinical Correlation


1 Department of Physiology, Career Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
2 Department of Obstetrics and Gynaecology, King George Medical University, Lucknow, Uttar Pradesh, India
3 Department of Medicine, King George Medical University, Lucknow, Uttar Pradesh, India

Date of Submission04-Feb-2018
Date of Acceptance07-Mar-2018
Date of Web Publication31-May-2018

Correspondence Address:
Rekha Sachan
Department of Obstetrics and Gynaecology, King George Medical University
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/apjon.apjon_15_18

Rights and Permissions
  Abstract 


Objective: The objective of the study is to evaluate the use of the Pap smear screening method for detection of precancerous lesions. Methods: All women who visited the outpatient gynecology clinic of the Department of Obstetrics and Gynaecology at King Georges Medical University, Lucknow, UP, India, over 1 year for different clinical problems were recruited for the study. A total of 1650 women who were sexually active and over 21 years of age were enrolled in the study. A clinical examination, an examination per speculum, and a vaginal examination were performed and a history taken for all women. A Pap smear was used for all women to screen for cervical cancer. The smear was obtained using an Ayre spatula and spread over a marked glass slide, which was placed in 95% ethyl alcohol and sent to the Department of Pathology for cytopathological examination. All data were recorded using a predetermined pro forma. Women who had visible malignant cervical lesions were excluded from the study. Results: Most women were in the age range of 30–50 years and multiparous. Vaginal discharge was the most common complaint, occurring in 36.96% of the women. An irregular menstrual cycle was the complaint of 12.78% and abdominal pain of 25.63% of women, while 15.15% were asymptomatic. The Pap smear test of 93.57% of the women was adequately taken, while 6.42% of the individuals had an inadequate sample. The test was negative for malignancy in 48.84%, and 42.66% had infection or inflammation. Atypical squamous cells of undetermined significance (ASCUS), low-grade squamous intraepithelial lesion (LSIL), and high-grade squamous intraepithelial lesion (HSIL) were detected in 2.90%, 5.09%, and 0.48%, respectively. Women with Pap tests positive for ASCUS, LSIL, and HSIL underwent a colposcopy and guided biopsy. Conclusions: Women with an abnormal Pap test should undergo a colposcopy, and those with abnormal colposcopy findings should be advised to undergo a biopsy. A Pap smear is simple, noninvasive, cost-effective, and easy to perform for detection of precancerous lesions in a gynecological patient.

Keywords: Cervical malignancy, HPV DNA testing, Pap smear


How to cite this article:
Sachan PL, Singh M, Patel ML, Sachan R. A Study on Cervical Cancer Screening Using Pap Smear Test and Clinical Correlation. Asia Pac J Oncol Nurs 2018;5:337-41

How to cite this URL:
Sachan PL, Singh M, Patel ML, Sachan R. A Study on Cervical Cancer Screening Using Pap Smear Test and Clinical Correlation. Asia Pac J Oncol Nurs [serial online] 2018 [cited 2019 Dec 10];5:337-41. Available from: http://www.apjon.org/text.asp?2018/5/3/337/233625




  Introduction Top


Cancer of the cervix is an increasing health problem and an important cause of mortality in women worldwide. The incidence of cervical cancer arises worldwide. The difference in incidence between developing and developed countries, where cervical cancer cases have been significantly reduced, is large. In developing countries like India, the burden of cervical cancer is still high. According to the World Cancer statistics, >80% of all the cervical cancer cases are found in developing and low-resource countries, because of a lack of awareness and difficulty in running cytology-based screening programs.[1] More than one-fifth of all cervical cancer deaths occur in India.[2] Every year, 122,844 women in India are diagnosed with cervical cancer, and 67,477 women die from the disease.[3]

Cervical cancer is a preventable disease due to the long preinvasive stage. Early detection and appropriate treatment are possible if robust screening is implemented.[4] Early cervical epithelial changes can be identified by a  Pap smear More Details test, which is the primary screening test for detection of precancerous cervical intraepithelial neoplasia and the early stage of invasive cervical cancer.

Due to widespread screening programs, there has been a significant reduction in mortality from cervical cancer in developed countries.

The overall sensitivity of the Pap test in detecting a high-grade squamous intraepithelial lesion (HSIL) is 70.80%.[5] A Pap screening done in association with an HPV DNA test increases the sensitivity for early detection of precancerous lesions.[6]

There is a need to spread cervical cancer screening awareness programs, educate women regarding the symptoms of cancer, and motivate them to visit the hospital for a cancer screening. Women and all family members should be counseled about the need for cancer screening. Pap smear-positive women need adequate treatment and regular follow-up. Thus, we have to strengthen our health services and health-care system to include screening at primary health centers.

The aim of the present study was to evaluate women for precancerous lesions using the Pap smear test and investigate clinical correlation.


  Methods Top


This prospective study was carried out over 1 year at the Department of Obstetrics and Gynaecology in Queen Mary's Hospital, part of King George Medical University, Lucknow, India. We screened 1650 sexually active women who were more than 21 years of age. Women with different complaints, including vaginal discharge, blood-mixed discharge, foul-smelling discharge, postcoital bleeding, intermenstrual bleeding, postmenopausal bleeding, abdominal pain, infertility, and secondary amenorrhea, were included in this study. Those not willing to participate in the study had a frank growth, had been treated for cervical cancer, or were pregnant were excluded from the study. A detailed history was taken using a predetermined pro forma that included the chief complaint and the findings of per speculum and vaginal examinations.

Written informed consent was obtained from all women. Patients were placed in the lithotomy position, and a sterile bivalve speculum was inserted into the vagina. The posterior vaginal wall was retracted posteriorly and the anterior vaginal wall anteriorly to allow proper visualization of the cervix and vaginal wall.

A sample was taken from the ectocervix by rotating a wooden Ayre spatula 360°. The sample was quickly smeared onto a labeled glass slide and fixed with 95% ethyl alcohol in a jar. The glass slides were sent to the Department of Pathology for cytopathological examination. Laboratory results were reported according to the new Bethesda System for Reporting Cervical Cytology 2014. The system broadly divides lesions into those negative for intraepithelial neoplasia and epithelial cell abnormalities (ECA) that include squamous and glandular cells.

Women who had abnormal Pap test results, including atypical squamous cells of undetermined significance (ASCUS), low-grade squamous intraepithelial lesion (LSIL), and HSIL were sent for a colposcopic examination. Women who had an abnormal colposcopic finding, i.e., a Reid score 6 or above, underwent a colposcopy-guided biopsy. Treatment was provided according to the stage of the disease.


  Results Top


In this study, most women (54) with LSIL belonged to the 41–50-year-old age group, followed by 17 women who belonged to the 51–60-year-old age group. HSIL was found mostly in women 41–50 years of age [Table 1]. Most women with LSIL had four or more children. This indicates that multiparity (>3) is a significant risk factor for cervical carcinoma.
Table 1: Demographic Profile of patients

Click here to view


Most women in the study were Hindu, not Muslim. May be fewer Muslim women came to the hospital because of their religion, shyness, or they were unaware of the cervical cancer screening program. Most women belonged to rural communities versus urban areas because the government runs the cervical cancer screening awareness program in rural areas [Table 1].

White vaginal discharge was the most common symptom found in 36.96%, abdominal pain in 25.63%, an irregular menstrual cycle in 12.78%, postcoital bleeding in 3.09%, and postmenopausal bleeding in 1.45% of the women [Table 2].
Table 2: Symptoms of women attending gynaecological outdoor

Click here to view


[Table 3] shows that on perspeculum examination white discharge was commonly found in 29.69% of the participants, cervical erosion was present in 19.21%, hypertrophy of the cervix was found in 10.84%, and cervical bleeding on touch was found in 4.84%. Cases with chronic cervicitis and cervical bleeding on touch had epithelial abnormalities.
Table 3: Per speculum examination findings of gynaecological cases

Click here to view


[Table 4] shows that 48.84% of the participants were negative for malignancy and 42.66% had inflammation. The epithelial abnormalities ASCUS, LSIL, and HSIL were found in 2.90%, 5.09%, and 0.48% of the women, respectively. Unsatisfactory reporting occurred for 6.42%, while the remainder had adequate sample reporting.
Table 4: According to epithelial cell abnormality

Click here to view


The results in [Table 5] show that the most abnormal Pap smear findings were found in patients with symptoms of white vaginal discharge, followed by patients with abdominal pain. No LSIL and HSIL was found for patients with postcoital bleeding, and HSIL was found in only two patients with postmenopausal bleeding.
Table 5: Correlation of pap smear finding with symptoms

Click here to view



  Discussion Top


The incidence of cervical cancer is quite high because prevention programs are either nonexistent or poorly implemented. The Pap smear test used as a screening method to detect cervical cancer is an effective way to prevent the development of cervical cancer, but awareness within the community about the Pap smear test is very low. According to the American Cancer Society (2012), the Pap smear test is a routine cancer screening method that should be done every 3 years, and a Pap smear with an HPV DNA test is recommended as a screening method every 5 years.[7]

In the present study, most of the abnormal cytology was detected in patients in the age group between 40 and 60 years. LSIL and HSIL were found in 5.09% and 0.48% of the women in this age group, respectively. Gupta et al.[8] reported that most of the abnormal cytology cases, i.e., 40.37%, in their study were in the age group of 30–39 years, followed by 35.96% in the age group of 20–29 years. LSIL was found in 1.36% (age group of 30–39 years) and HSIL in 0.91% (age group of 40–49 years). Vaghela et al.[9] reported that LSIL was the most common epithelial abnormality, found in 12.4% of their individuals, followed by HSIL in 5% of the cases. For all epithelial abnormalities, the average age of the women was 49 years.

White vaginal discharge was the most common complaint of the women in our study at 36.96%, similar to the rate in other studies.[10],[11]

The Pap smear was negative for malignancy in 48.84%, but 42.66% had inflammation. Other studies [12],[13] reported 95% and 74.5% had inflammation indicated by the Pap smear test, respectively. A few studies [14],[15] reported that women with persistent inflammation should be appropriately treated; otherwise, the chance of development of cervical intraepithelial lesions increases. A repeat Pap smear should be taken after proper antibiotic treatment.

Our study had an unsatisfactory report rate of 6.42%, which might have been due to dryness of the smear or a technical error. The 4.8% unsatisfactory report rate reported by Vaghela et al.[9] might have been due to proper training of personnel and the use of the proper technique.

ECA was detected in 8.48% of our screened women, a result comparable to the ECA detection rates of 9.05%, 12.60%, and 11.95% in the studies performed by Al Eyd et al.,[16] Patel et al.,[6] and Sarma et al.,[17] respectively.

In our study, the ECA ASCUS was found in 2.9% of screened women, LSIL in 5.09%, and HSIL in 0.48%, results comparable to those in a study done by Verma et al.,[18] who found ASCUS in 1%, LSIL in 5.5%, and HSIL in 2.5% of their screened women. Padmini et al.[19] also reported ASCUS (8%), LSIL (5%), and HSIL (3%) in women screened with the Pap smear test. Higher numbers of LSIL (8.6%) and HSIL (3.8%) lesions were found in a study by Nayani and Hendre.[20] The high prevalence of cytological abnormality observed in Indian studies might be due to cultural differences, age of the individuals, incidence of related infections, awareness about screening, and the presence or absence of cervical screening programs in different parts of the country. A Saudi Arabian study [21] had a 4.9% detection rate for the epithelial pathological diagnosis of SIL. The higher SIL rate was a result of a lack of awareness about screening and a lack of screening programs. In contrast to our study, Saha et al.[22] reported ASCUS (5.92%) to be the most common cytological abnormality.

Cervical cancer commonly develops in women between the ages of 40 and 50 years and its precursor lesion usually occurs 5–10 years earlier. Therefore, it is recommended that women should have at least one Pap smear test before the age of 45 years.[23],[24]


  Conclusion Top


Pap smear testing is a very useful, simple, economical, and safe tool for detecting precancerous cervical epithelial lesions. It should be established as a routine screening procedure to reduce the treatment burden, morbidity, and mortality. Every woman above the age of 30 years should undergo routine cervical cancer screening, even into the postmenopausal period. The Pap test has been regarded as the gold standard of cervical screening programs. When the Pap test is combined with an HPV DNA test, the sensitivity for detection of cervical pathology is increased. The community should be educated about the Pap smear test, including its goal and the required frequency of application, by widespread educational and media programs. Most women who visited an outpatient clinic are not aware of cervical cancer screening. Thus, there is a need to spread cancer screening programs to help prevent mortality and morbidity due to cervical cancer.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015;136:E359-86.  Back to cited text no. 1
    
2.
Bruni L, Barrionuevo-Rosas L, Albero G, Aldea M, Serrano B, Valencia S, et al. ICO Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases Reports. Available from: http://www.hpvcentre.net/statistics/reports/XWX.pdf. [Last accessed on 2015 Mar 20].  Back to cited text no. 2
    
3.
ICO Information Centre on HPV and Cancer. Human Papillomavirus and Related Diseases in India (Summary Report 2014-08-22); 2014.  Back to cited text no. 3
    
4.
Bal MS, Goyal R, Suri AK, Mohi MK. Detection of abnormal cervical cytology in papanicolaou smears. J Cytol 2012;29:45-7.  Back to cited text no. 4
[PUBMED]  [Full text]  
5.
Ansari M, Mehdi G, Arif SH, Ansari H, Khan T. Smear patterns and spectrum of premalignant and malignant cervical epithelial lesions in postmenopausal Indian women: A hospital-based study. Diagn Cytopathol 2012;40:976-83.  Back to cited text no. 5
    
6.
Patel MM, Pandya AN, Modi J. Cervical pap smear study and its utility in cancer screening, to specify the strategy for cervical cancer control. Natl J Community Med 2011;2:49-51.  Back to cited text no. 6
    
7.
Saslow D, Solomon D, Lawson HW, Killackey M, Kulasingam SL, Cain J, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin 2012;62:147-72.  Back to cited text no. 7
    
8.
Gupta K, Malik NP, Sharma VK, Verma N, Gupta A. Prevalence of cervical dysplasia in Western Uttar Pradesh. J Cytol 2013;30:257-62.  Back to cited text no. 8
[PUBMED]  [Full text]  
9.
Vaghela BK, Vaghela VK, Santwani PM. Analysis of abnormal cervical cytology in papanicolaou smears at tertiary care center – A retrospective study. IJBAR 2014;5:47-9.  Back to cited text no. 9
    
10.
Pradhan B, Pradhan SB, Mital VP. Correlation of PAP smear findings with clinical findings and cervical biopsy. Kathmandu Univ Med J (KUMJ) 2007;5:461-7.  Back to cited text no. 10
    
11.
Ranabhat SK, Shrestha R, Tiwari M. Analysis of abnormal epithelial lesions in cervical pap smears in mid-Western Nepal. J Pathol Nepal 2011;1:30-3.  Back to cited text no. 11
    
12.
Atilgan R, Celik A, Boztosun A, Ilter E, Yalta T, Ozercan R, et al. Evaluation of cervical cytological abnormalities in Turkish population. Indian J Pathol Microbiol 2012;55:52-5.  Back to cited text no. 12
  [Full text]  
13.
Kulkarni PR, Rani H, Vimalambike MG, Ravishankar S. Opportunistic screening for cervical cancer in a tertiary hospital in Karnataka, India. Asian Pac J Cancer Prev 2013;14:5101-5.  Back to cited text no. 13
    
14.
Bhutia K, Puri M, Gami N, Aggarwal K, Trivedi SS. Persistent inflammation on pap smear: Does it warrant evaluation? Indian J Cancer 2011;48:220-2.  Back to cited text no. 14
[PUBMED]  [Full text]  
15.
Barouti E, Farzaneh F, Sene A. The pathogenic microorganism in papanicolaou vaginal smears and correlation with inflammation. J Family Reproduct Health 2013;7:23-7.  Back to cited text no. 15
    
16.
Al Eyd GJ, Shaik RB. Rate of opportunistic pap smear screening and patterns of epithelial cell abnormalities in pap smears in Ajman, United Arab Emirates. Sultan Qaboos Univ Med J 2012;12:473-8.  Back to cited text no. 16
    
17.
Sarma U, Mahanta J, Talukdar K. Pattern of abnormal cervical cytology in women attending a tertiary hospital. Int J Sci Res Publ 2012;2:1-4.  Back to cited text no. 17
    
18.
Verma A, Verma S, Vashist S, Attri S, Singhal A. A study on cervical cancer screening in symptomatic women using pap smear in a tertiary care hospital in rural area of Himachal Pradesh, India. Middle East Fertil Soc J 2017;22:39-42.  Back to cited text no. 18
    
19.
Padmini CP, Indira N, Chaitra R, Das P, Girish BC, Nanda KM, et al. Cytological and colposcopic evaluation of unhealthy cervix. J Evid Med Healthc 2015;2:6920-7.  Back to cited text no. 19
    
20.
Nayani ZS, Hendre PC. Comparison and correlation of pap smear with colposcopy and histopathology in evaluation of cervix. J Evol Med Dent Sci 2015;4:9236-47.  Back to cited text no. 20
    
21.
Magdy HB, Mohammed SM, Naema G, Souad O. Cytological pattern of cervical papanicolaou smear in eastern region of Saudi Arabia. J Cytol 2011;28:173-7.  Back to cited text no. 21
    
22.
Saha D, Ghosh S, Nath S, Islam H. Utility of pap smear screening for prevention of cervical cancer – A 3yrs study from rural Tripura – A northeastern state of India. Int J Med and Dent Sci 2017;6:1456-61.  Back to cited text no. 22
    
23.
Shanmugham D, Vijay A, Rangaswamy T. Colposcopic evaluation of patient with persistant inflammatory papsmear. Sch J Appl Med Sci 2014;2:1010-3.  Back to cited text no. 23
    
24.
Maleki A, Ahmadnia E, Avazeh A, Mazloomzadeh S, Molaei B, Jalilvand A, et al. Prevalence of abnormal papanicolaou test results and related factors among women living in Zanjan, Iran. Asian Pac J Cancer Prev 2015;16:6935-9.  Back to cited text no. 24
    

 
  Authors Top

Rekha Sachan



 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5]


This article has been cited by
1 Gold-Hybridized Zinc Oxide Nanorods as Real-Time Low-Cost NanoBiosensors for Detection of virulent DNA signature of HPV-16 in Cervical Carcinoma
Thevendran Ramesh,Kai Loong Foo,Haarindraprasad R.,Annie Jeyachristy Sam,Maheswaran Solayappan
Scientific Reports. 2019; 9(1)
[Pubmed] | [DOI]
2 Identification of CD28 and PTEN as novel prognostic markers for cervical cancer
Fujin Shen,Hongyun Zheng,Limei Zhou,Wei Li,Juan Liu,Xuexian Xu
Journal of Cellular Physiology. 2018;
[Pubmed] | [DOI]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Methods
Results
Discussion
Conclusion
References
Authors
Article Tables

 Article Access Statistics
    Viewed2382    
    Printed57    
    Emailed0    
    PDF Downloaded319    
    Comments [Add]    
    Cited by others 2    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]